We are pleased to welcome Dr. Andreas Schemenewitz as the new managing director of IHF GmbH. Dr. Schemenewitz looks back on 17 years of experience in clinical research. In addition to operational activities in the management of clinical trials at two renowned pharmaceutical companies, Dr. Schemenewitz has profound expertise in the segment of contract research with a focus on business development and sales as well as management and executive management. Before joining IHF GmbH, Dr. Schemenewitz successfully worked as managing director for a contract research organisation and consultancy focusing on natural health products.
Prof. Dr. Jochen Senges, Chairman of the Board of the foundation IHF Institute for Myocardial Infarction Research: "We are delighted to have won Dr. Schemenewitz to manage our company. His experience and knowledge will be of great value to continue to successfully manage IHF GmbH in the future and to ensure the excellent service that our customers and partners expect from a consulting institution".
"From the very first day, I was very welcome and felt the high motivation and commitment of all colleagues to further develop our company together based on a great expertise and to expand the position that we hold in the market as a competent and reliable contract research organisation. I gratefully appreciate the confidence expressed and look forward to a continuing successful team work," said Dr. Schemenewitz.
About IHF - Institute for Myocardial Infarction
For more than 20 years, the non-profit foundation IHF Institute for Myocardial Infarction Research Ludwigshafen has been an Academic Research Organisation promoting scientific clinical research in the field of cardiovascular diseases, in particular care research and quality assurance in everyday clinical practice. The IHF GmbH, as a 100% affiliate of the IHF Foundation, is a Clinical Research Organisation that supports clinical institutions in the execution of their research projects and is also a competent and reliable partner in industry-sponsored clinical research and development.
More information about the institutes is available at www.stiftung-ihf.de and www.ihf.de